Matching slides 33,236
Current window 13,771-13,800
Pages 1,108
Rows per page 30
Arc: Monroes Sequenceclear collectionreset all

Arc

13,771-13,800 of 33,236

filter-aware
20
The slide uses a mix of bar charts and line charts with trend lines to illustrate recovery.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
21
Includes a bar chart showing organic growth over time and a bar chart comparing retail prescription growth across products.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
22
The slide uses trend lines to highlight recovery and strong performance across three distinct product lines.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
23
Includes a map-based visualization of regional product performance and a donut chart for revenue breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
24
Includes CAGR annotations on bar charts.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
25
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
26
The slide uses a three-column layout to organize leadership bios by company.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
27
Includes product imagery for Solta Medical brands (Thermage, Clear + Brilliant, Fraxel, Vaser).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
28
The slide uses a combination of a checklist (left) and a process flow diagram (right) to communicate the deleveraging strategy.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
29
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
30
Standard corporate 'at-a-glance' summary slide.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
31
The slide uses a grid of icons and metrics to present company fundamentals and market size.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
32
Includes disclaimer about non-retouched photos and medical source credits.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a flow diagram to show how business lines were reallocated between two reporting periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
The slide details the financial impact of segment realignments, showing reported vs. restated figures.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a three-column layout to categorize updates by business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a grid-based timeline to map four distinct drug development programs against calendar years from 2019 to 2027.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks financial performance changes for specific product lines following patent expirations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
LOE stands for Loss of Exclusivity. The table tracks financial variance between two forecast periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
The table compares inventory levels across two years, highlighting the change in months on hand for each business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
The table highlights inventory levels for specific business units, showing an increase in months on hand across all units in the 2021 period compared to 2020.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The slide highlights a 6% organic revenue growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The slide highlights a 1% organic revenue decline for the segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
Includes segment-specific revenue and operating expense breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide includes a specific callout for the revenue decline of the WELLBUTRIN/APLENZIN product line.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
Includes detailed footnotes regarding non-GAAP adjustments and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit